The cost effectiveness of cardiovascular medicines.
Hay
Joel
J
Department of Pharmaceutical Economics and Policy, University of Southern California, Center for the Health Professions CHP-140, 1540 E. Alcazar Street, Los Angeles, CA 90089, USA. JHay@usc.edu
D002317:Cardiovascular Agents / Q000191:economics* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000191:economics*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005102:Health Expenditures; D006801:Humans; D014481:United States
D002317:Cardiovascular Agents
BMJ. 2003 Jun 28;326(7404):1419
12829553
Milbank Q. 1998;76(4):517-63, 509
9879302
Curr Control Trials Cardiovasc Med. 2004 Jun 4;5(1):4
15180910
Am Heart J. 2000 Jan;139(1 Pt 1):106-13
10618570
Am J Manag Care. 2003 Jun;9 Spec No 1:SP13-24
12817612
BMJ. 1998 Sep 12;317(7160):720-6
9732339
Health Aff (Millwood). 2004 Jan-Feb;23(1):147-59
15002637